Senior management changes at EDBI
EDBI announces changes to management that will take effect from 1 February 2023.
Our Inaugural Sustainability Report 2021/2022
Investing in a resilient and sustainable future EDBI Sustainability Report 2021/2022 Recognising the importance of how investors play an influential role in encouraging sustainability, EDBI is doing our part to contribute to Singapore’s commitments towards a more sustainable world. Our inaugural sustainability report charts our role as a strategic investor and outlines our ESG practices …
The Perks of Investing in Real Time Data
A video interview by Singapore Business Review featuring Deb Dutta (DataStax) and Paul Ng (EDBI) on how real time data applications can help organisations innovate and adopt technologies to build a smarter Singapore.
DataStax Secures $115 Million Investment led by Goldman Sachs Asset Management
DataStax, the real-time data company, announced that it has secured $115 million in funding led by the Growth Equity business within Goldman Sachs, with participation from Rokos Capital and Singapore-based global investor EDBI.
Tessa Therapeutics Completes US$126 Million Financing Led by Polaris Partners
Tessa Therapeutics, a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced the close of a US$126 million Series A financing round.
Aspen Neuroscience Announces $147.5 Million Series B Financing, led by GV, LYFE Capital and Revelation Partners
Aspen Neuroscience, Inc., a private biotechnology company developing autologous cell therapies, including the first iPSC-derived autologous neuron replacement treatment for Parkinson’s disease, announced the close of its Series B funding round of $147.5 million.
Singapore’s Neuron Mobility Triples its Global Operations and Raises US$43.5 Million to Fuel Rapid International Expansion and Accelerate Tech Leadership
Neuron Mobility, Canada’s fastest-growing shared e-scooter and e-bike operator, announces it has successfully raised US$43.5 million in Series B funding. This follows 19 months of significant growth and brings the company’s total funding to US$77.7 million.
WalkMe Establishes Asia Pacific Headquarters in Singapore
WalkMe, a leading provider of digital adoption platforms, announced the opening of its Asia Pacific headquarters in Singapore. The office was officially opened by Raphael Sweary, President and Co-founder, WalkMe at an exclusive event with senior executives from EDBI and IMDA.
Ambiq Expands to Singapore with a New Technology Design Center
Ambiq®, a leading developer of ultra-low-power semiconductor solutions that deliver a multifold increase in energy efficiency, announces the grand opening of its new Technology Design Center in Singapore.
RVAC Medicines, a CBC-Incubated mRNA Platform Company, Raises US$140 Million to Expand R&D and Manufacturing Capacity
RVAC Medicines, an emerging messenger RNA (mRNA) platform company incubated in Singapore by CBC Group, announced the completion of its series B financing, bringing the company’s total funds raised since its inception in June 2021 to US$140 million.
